Research
Hormonal
In Type 1 Diabetes, fracture incidence rates have remained stable or increased in women, despite overall improvements in diabetes management and the adoption of newer technologies.
If you have Type 1 Diabetes, especially if you are a woman, be aware that your fracture risk may not be decreasing as much as it is for Type 2 Diabetes patients. Focus on preventing hypoglycemia, as low blood sugar events are linked to higher fracture risk. Discuss bone health specifically with your endocrinologist.
GoodRefutesHIGH confidence
The trends in the IRs of fractures remained higher and unchanged in persons with T1D in all age groups except for the youngest age group (18–29 years)... we observed a stable trend in IRs of fractures in persons with T1D (p = 0.85)
Why this rating
Large registry data, but observational nature limits causal attribution for the stable trend.
Source
Effects of Incretin Therapy on Skeletal Health in Type 2 Diabetes—A Systematic Review
Rikke Viggers et al. · JBMR Plus · 2023
DOI 10.1002/jbm4.10817
cohort · n=1235628Cited 18×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →